S 667 Massachusetts Senate · 193rd Legislature (2023-2024)

An Act to prohibit cost sharing for opioid antagonists

This bill requires various health insurance plans in Massachusetts to cover opioid antagonists, such as naloxone, without charging patients any copay or coinsurance. It directly affects state employees, Medicaid participants, and individuals with private insurance policies issued within the state. The law allows these drugs to be covered under statewide standing orders, meaning a prescription from a doctor is not needed to receive the medication. The only exception to the no-cost rule is for plans governed by federal tax laws that would lose their tax-exempt status if they eliminated cost-sharing for this service.
Bill status passed 3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Mar 2024
House Passage
Feb 2023
Governor
Introduced Feb 16, 2023 Last action May 9, 2024
Floor votes

How they voted

This bill passed the House. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
5
Key actions
1
Committee
2
Mar 11, 2024
Senate · Reported by committee
Bill reported favorably by committee and referred to the committee on Health Care Financing
Feb 16, 2023
House · Passed
House concurred
Feb 16, 2023
Senate · Referred to committee
Referred to the committee on Financial Services
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Jason Lewis
Jason Lewis
DDemocratic
MA
Fifth Middlesex